BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 26375669)

  • 1. Elevated expression of Cripto-1 correlates with poor prognosis in hepatocellular carcinoma.
    Wang JH; Wei W; Xu J; Guo ZX; Xiao CZ; Zhang YF; Jian PE; Wu XL; Shi M; Guo RP
    Oncotarget; 2015 Oct; 6(33):35116-28. PubMed ID: 26375669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased Cezanne expression is associated with the progression and poor prognosis in hepatocellular carcinoma.
    Wang JH; Wei W; Guo ZX; Shi M; Guo RP
    J Transl Med; 2015 Feb; 13():41. PubMed ID: 25638165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of MMP-9 over MMP-2 in HCC invasiveness and recurrence of hepatocellular carcinoma after curative resection.
    Chen R; Cui J; Xu C; Xue T; Guo K; Gao D; Liu Y; Ye S; Ren Z
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S375-84. PubMed ID: 21681378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
    Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
    World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of Cripto-1 for transarterial chemoembolization in hepatocellular carcinoma.
    Li XS; Wang JH; Yang XZ; Ma L; Shi YX; Song Y; Jiang P; Gao S; Dong Y; Lin JR; Jin C
    Aging (Albany NY); 2019 May; 11(10):2998-3011. PubMed ID: 31136302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GPX2 overexpression indicates poor prognosis in patients with hepatocellular carcinoma.
    Liu T; Kan XF; Ma C; Chen LL; Cheng TT; Zou ZW; Li Y; Cao FJ; Zhang WJ; Yao J; Li PD
    Tumour Biol; 2017 Jun; 39(6):1010428317700410. PubMed ID: 28635398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis.
    Ha SY; Kim JH; Yang JW; Kim J; Kim B; Park CK
    Cancer Res Treat; 2016 Jul; 48(3):1065-73. PubMed ID: 26511806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Notch1 and Notch4 are markers for poor prognosis of hepatocellular carcinoma.
    Ahn S; Hyeon J; Park CK
    Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):286-94. PubMed ID: 23742774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
    Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
    Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HOXC6 predicts invasion and poor survival in hepatocellular carcinoma by driving epithelial-mesenchymal transition.
    Li PD; Chen P; Peng X; Ma C; Zhang WJ; Dai XF
    Aging (Albany NY); 2018 Jan; 10(1):115-130. PubMed ID: 29348394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of betaine homocysteine methyltransferase (BHMT) in hepatocellular carcinoma associates with poor prognosis.
    Jin B; Gong Z; Yang N; Huang Z; Zeng S; Chen H; Hu S; Pan G
    Tumour Biol; 2016 May; 37(5):5911-7. PubMed ID: 26592251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ITPKA expression is a novel prognostic factor in hepatocellular carcinoma.
    Li J; Zhu YH; Huang P; Zhang B; Sun J; Guan XY
    Diagn Pathol; 2015 Aug; 10():136. PubMed ID: 26249031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cripto-1 expression and its prognostic value in human bladder cancer patients.
    Wei B; Jin W; Ruan J; Xu Z; Zhou Y; Liang J; Cheng H; Jin K; Huang X; Lu P; Hu Q
    Tumour Biol; 2015 Feb; 36(2):1105-13. PubMed ID: 25326807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of SALL4 in the development and prognosis of hepatocellular carcinoma.
    Yin F; Han X; Yao SK; Wang XL; Yang HC
    World J Gastroenterol; 2016 Mar; 22(9):2837-43. PubMed ID: 26973422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis.
    Zhang QB; Jia QA; Wang H; Hu CX; Sun D; Jiang RD; Zhang ZL
    BMC Cancer; 2016 Nov; 16(1):880. PubMed ID: 27836008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of myofibrillogenesis regulator-1 predicts poor prognosis for patients with hepatocellular carcinoma after curative hepatectomy.
    Wang C; Xiang H; Si H; Guo D; Sun M
    Int J Clin Exp Pathol; 2015; 8(11):14818-23. PubMed ID: 26823810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and prognostic implications of pretreatment albumin to C-reactive protein ratio in patients with hepatocellular carcinoma.
    Wu MT; He SY; Chen SL; Li LF; He ZQ; Zhu YY; He X; Chen H
    BMC Cancer; 2019 Jun; 19(1):538. PubMed ID: 31164099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Jagged2 and Gli1 expression and their correlation with prognosis in human hepatocellular carcinoma.
    Zhang J; Tu K; Yang W; Li C; Yao Y; Zheng X; Liu Q
    Mol Med Rep; 2014 Aug; 10(2):749-54. PubMed ID: 24858621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.